Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Test    symbols : Ocx    save search

Oncocyte Begins Manufacturing Transplant Blood Test
Published: 2023-06-27 (Crawled : 12:00) - globenewswire.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: -0.43% H: 2.38% C: 2.05%

test blood
DetermaIO™ Clinical Test to be used in SWOG Cancer Research Network Biomarker Study for Breast Cancer
Published: 2022-10-06 (Crawled : 20:00) - biospace.com/
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: 0.03% H: 9.14% C: 4.24%

research test breast biomarker cancer study
Oncocyte Completes Validation of TheraSure™ Transplant Monitor Test Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
Published: 2022-05-05 (Crawled : 20:00) - biospace.com/
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: -1.65% H: 5.88% C: 0.0%

treatment test
14 Tage zu einem besseren trustly casino betrugstest
Published: 2021-12-15 (Crawled : 19:00) - oncocyte.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: 1.65% H: 0.0% C: 0.0%

trust test
Spotlight Poster Presentation at San Antonio Breast Cancer Symposium SABCS 2021 Shows Oncocyte’s DetermaIO™ Clinical Test Predicts Response to Immunotherapy in Triple Negative Breast Cancer
Published: 2021-12-09 (Crawled : 00:00) - globenewswire.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: -0.37% H: 0.0% C: 0.0%

symposium sabcs presentation immunotherapy test therapy cancer negative breast cancer
Wie man mit testosteron enantat shop in 10 Minuten besser wird
Published: 2021-12-01 (Crawled : 05:00) - oncocyte.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: -1.71% H: 0.0% C: 0.0%

test
These 10 Hacks Will Make Your testosterone enanthate for sale uk Look Like A Pro
Published: 2021-11-30 (Crawled : 05:00) - oncocyte.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: -5.65% H: 0.0% C: 0.0%

test
What Is buy test enanthate uk and How Does It Work?
Published: 2021-11-30 (Crawled : 05:00) - oncocyte.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: -5.65% H: 0.0% C: 0.0%

test
The 3 Really Obvious Ways To testosterone enanthate buy Better That You Ever Did
Published: 2021-11-30 (Crawled : 05:00) - oncocyte.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: -5.65% H: 0.0% C: 0.0%

test
3 Gründe, warum Facebook die schlechteste Option für steroide bodybuilder ist
Published: 2021-11-27 (Crawled : 00:20) - oncocyte.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

test
Le guide ultime du testostérone injection prix
Published: 2021-11-20 (Crawled : 00:20) - oncocyte.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

test injection
Who Else Wants To Be Successful With buy testosterone online in 2021
Published: 2021-11-18 (Crawled : 11:00) - oncocyte.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: -2.01% H: 3.08% C: -3.08%

test
3 einfache Möglichkeiten, testosterone kaufen schneller zu machen
Published: 2021-11-12 (Crawled : 19:00) - oncocyte.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

test
9 Key Tactics The Pros Use For how to buy testosterone enanthate
Published: 2021-11-04 (Crawled : 14:00) - oncocyte.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: 2.79% H: 0.0% C: 0.0%

test
In-Vitro Colorectal Cancer Screening Tests Market revenue to cross USD 1.12 Bn by 2027: Global Market Insights Inc.
Published: 2021-10-20 (Crawled : 12:00) - prnewswire.com
EXAS | $63.21 -1.02% -1.03% 2.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.29% H: 0.17% C: -1.15%
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: -0.31% H: 6.21% C: 3.73%

test cancer colorectal cancer in vitro
Oncocyte Announces Oral Presentation of New Data on Its DetermaIO™ Immunotherapy Response Test at the European Society for Medical Oncology Annual Meeting
Published: 2021-09-20 (Crawled : 16:00) - globenewswire.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: -2.52% H: 10.59% C: -0.52%

presentation immunotherapy europe test therapy
Oncocyte Announces Collaboration with Gruppo Oncologico del Nord Ovest to Evaluate Oncocyte’s DetermaIO Test in Colorectal Cancer, the Second Leading Cause of Cancer Mortality Globally
Published: 2021-06-03 (Crawled : 12:15) - globenewswire.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: -0.43% H: 8.44% C: 8.44%

test collaboration cancer announces collaboration colorectal cancer
Oncocyte to Present New Data on DetermaIO™ Test as a Predictor of Immunotherapy Response in Renal Cell Cancer at the 2021 ASCO Annual Meeting
Published: 2021-04-28 (Crawled : 21:00) - globenewswire.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: 0.6% H: 0.0% C: -1.39%

immunotherapy renal test therapy cancer
Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China
Published: 2020-12-15 (Crawled : 07:00) - globenewswire.com
BNR | $0.81 6.57% 6.16% 4.3K twitter stocktwits trandingview |
Health Services
| | O: -1.1% H: 1.72% C: 1.15%
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: 62.74% H: 1.74% C: -26.67%

license risk cancer china test lung cancer
Oncocyte Corporation Hosting Key Opinion Leader Call on Proprietary Molecular Tests for Cancer Treatment Selection
Published: 2020-12-07 (Crawled : 21:06) - globenewswire.com
OCX | News J | $2.75 4.89% 36K twitter stocktwits trandingview |
Health Technology
| | O: 1.01% H: 6.0% C: 3.5%

cancer test molecular treatment
Gainers vs Losers
56% 44%

Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M twitter stocktwits trandingview |
Health Technology

SINT | $0.0365 59.39% 37.26% 470M twitter stocktwits trandingview |
Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M twitter stocktwits trandingview |
Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M twitter stocktwits trandingview |

GCTK | $0.715 36.27% 26.62% 640K twitter stocktwits trandingview |
Manufacturing

TCON | $2.33 36.26% 26.61% 2M twitter stocktwits trandingview |
Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M twitter stocktwits trandingview |

KZIA | $0.38 30.58% 23.42% 300K twitter stocktwits trandingview |
Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M twitter stocktwits trandingview |
Health Technology

ATNF | $1.91 29.05% 22.51% 310K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.